Please note that this is the scientific program planned for 2020. We are currently talking to all the speakers and players with a view to implementing the program in the same or very similar form for 2021. Updates will follow shortly.

 

Scientific program

Preliminary program – Tuesday, November 10, 2020

10:00-11:00 am

Registration

11:00-11:15 am

Welcome Address

11:15 am - 12:45 pm

Session I – Precision Medicine Addressing Tolerance and Inflammation

Keynote: Kordasti, Shahram (Kings College London, London, UK)

12:45–1:30 pm

LunchPoster Session I

1:30-3:00 pm

Session II – Cell-based Therapy in Hematology

Keynote: Ciceri, Fabio (IRCCS Ospedale San Raffaele, Milan, Italy)

3:00-3:30 pm

Break

3:30-4:30 pm

Session III – Industry

Industry Session sponsored by Novartis

4:30-4:45 pm

Break

4:45-6:00 pm

Session IV – Cell-based Therapy in Oncology

Keynote: Abken, Hinrich (University Hospital Regensburg, Regensburg, Germany)

6:00-6:15 pm

Break

6:15-7:00 pm

Evening Lecture

T cell engaging therapies: Blinatumomab and beyond
Keynote: Bargou, Ralf (Julius-Maximilians-Universität (JMU), Würzburg, Germany)

The evening lecture is supported by:

from 7:00 pm

Get-together

 

 

Preliminary program – Wednesday, November 11, 2020

9:00-10:15 am

Session V – Combining Cell Therapy and Immune Checkpoint Inhibitors

Keynote: Chabannon, Christian (Institut Paoli-Calmettes, Marseille, France)

10:15-10:30 am

Break

10:30-11:45 am

Session VI – Biomarkers and Immuno Monitoring

Keynote: Dienstmann, Rodrigo (Vall d'Hebron Institute of Oncology, Barcelona, Spain)

11:45 am -12:00 pm

Break

12:00 - 1:00 pm

Session VII - Industry

Industry Session sponsored by Gilead

1:00-1:45 pm

LunchPoster Session II

1:45-3:00 pm

Session VIII – Improving the Efficacy and Safety Profile of Cell Therapies

Keynote: t.b.a.

3:00-3:15 pm

Break

3:15-4:30 pm

Session IX – Cancer Vaccines and Vector-based Therapy

Keynote: Cathomen, Tony (Medical Center – University of Freiburg, Freiburg, Germany)

from 4:30 pm

End